These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synthesis of part structures of Cryptococcus neoformans serotype C capsular polysaccharide. Guazzelli L; McCabe O; Oscarson S Carbohydr Res; 2016 Oct; 433():5-13. PubMed ID: 27423877 [TBL] [Abstract][Full Text] [Related]
3. Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine. Pirofski L; Lui R; DeShaw M; Kressel AB; Zhong Z Infect Immun; 1995 Aug; 63(8):3005-14. PubMed ID: 7622223 [TBL] [Abstract][Full Text] [Related]
5. Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. Casadevall A; Mukherjee J; Devi SJ; Schneerson R; Robbins JB; Scharff MD J Infect Dis; 1992 Jun; 165(6):1086-93. PubMed ID: 1583327 [TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies reveal additional epitopes of serotype D Cryptococcus neoformans capsular glucuronoxylomannan that elicit protective antibodies. Mukherjee J; Kozel TR; Casadevall A J Immunol; 1998 Oct; 161(7):3557-68. PubMed ID: 9759877 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies specific for immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, reduce serotype bias in an immunoassay for cryptococcal antigen. Percival A; Thorkildson P; Kozel TR Clin Vaccine Immunol; 2011 Aug; 18(8):1292-6. PubMed ID: 21697342 [TBL] [Abstract][Full Text] [Related]
8. A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection. Fleuridor R; Lees A; Pirofski L J Immunol; 2001 Jan; 166(2):1087-96. PubMed ID: 11145689 [TBL] [Abstract][Full Text] [Related]
9. Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles. Maitta RW; Datta K; Chang Q; Luo RX; Witover B; Subramaniam K; Pirofski LA Infect Immun; 2004 Aug; 72(8):4810-8. PubMed ID: 15271943 [TBL] [Abstract][Full Text] [Related]
10. A Paracoccidioides brasiliensis glycan shares serologic and functional properties with cryptococcal glucuronoxylomannan. Albuquerque PC; Cordero RJ; Fonseca FL; Peres da Silva R; Ramos CL; Miranda KR; Casadevall A; Puccia R; Nosanchuk JD; Nimrichter L; Guimaraes AJ; Rodrigues ML Fungal Genet Biol; 2012 Nov; 49(11):943-54. PubMed ID: 23010152 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and immunological studies of glycoconjugates of Cryptococcus neoformans capsular glucuronoxylomannan oligosaccharide structures. Oscarson S; Alpe M; Svahnberg P; Nakouzi A; Casadevall A Vaccine; 2005 Jun; 23(30):3961-72. PubMed ID: 15917118 [TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies reactive with immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans. Brandt S; Thorkildson P; Kozel TR Clin Diagn Lab Immunol; 2003 Sep; 10(5):903-9. PubMed ID: 12965925 [TBL] [Abstract][Full Text] [Related]
13. The structure of a Hargett AA; Azurmendi HF; Crawford CJ; Wear MP; Oscarson S; Casadevall A; Freedberg DI Proc Natl Acad Sci U S A; 2024 Feb; 121(7):e2315733121. PubMed ID: 38330012 [No Abstract] [Full Text] [Related]
14. Synthesis of a Glucuronic Acid-Containing Thioglycoside Trisaccharide Building Block and Its Use in the Assembly of Cryptococcus Neoformans Capsular Polysaccharide Fragments. Guazzelli L; Ulc R; Oscarson S ChemistryOpen; 2015 Dec; 4(6):729-39. PubMed ID: 27308199 [TBL] [Abstract][Full Text] [Related]
15. A synthetic strategy to xylose-containing thioglycoside tri- and tetrasaccharide building blocks corresponding to Cryptococcus neoformans capsular polysaccharide structures. Guazzelli L; Ulc R; Rydner L; Oscarson S Org Biomol Chem; 2015 Jun; 13(23):6598-610. PubMed ID: 25986781 [TBL] [Abstract][Full Text] [Related]
16. Molecular and idiotypic analysis of antibodies to Cryptococcus neoformans glucuronoxylomannan. Casadevall A; DeShaw M; Fan M; Dromer F; Kozel TR; Pirofski LA Infect Immun; 1994 Sep; 62(9):3864-72. PubMed ID: 8063403 [TBL] [Abstract][Full Text] [Related]